|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Articles in PresS, published online ahead of print December 5, 2002
Am J Physiol Heart Circ Physiol, 10.1152/ajpheart.00441.2002
Submitted on May 24, 2002
Accepted on November 25, 2002
1-adrenergic receptor (AR) responses in
1AB-AR knockout mouse hearts suggests presence of
1D-AR
1 Department of Radiology, University of California San Francisco, San Francisco, CA, USA; Cardiovascular Research Institute, University of California San Francisco, San Francisco, CA, USA; Department of Cardiology, Veterans Affairs Medical Center, San Francisco, CA, USA
2 Department of Radiology, University of California San Francisco, San Francisco, CA, USA; Department of Cardiology, Veterans Affairs Medical Center, San Francisco, CA, USA
3 Cardiovascular Research Institute, University of California San Francisco, San Francisco, CA, USA; Department of Cardiology, Veterans Affairs Medical Center, San Francisco, CA, USA
4 Department of Cardiology, Veterans Affairs Medical Center, San Francisco, CA, USA; Cardiovascular Research Institute, University of California San Francisco, San Francisco, CA, USA; Department of Medicine, University of California San Francisco, San Francisco, CA, USA
* To whom correspondence should be addressed. E-mail: ajbaker{at}itsa.ucsf.edu.
Two functional
1-adrenergic receptor (AR) subtypes (
1A and
1B) have been identified in the mouse heart. However, it is unclear if the third known subtype,
1D-AR, is also present. To investigate this, we determined if there were
1-AR responses in hearts from a novel mouse model lacking
1A- and
1B-ARs (ABKO). In Langendorff-perfused hearts,
1-ARs were stimulated with phenylephrine. For ABKO hearts, phenylephrine reduced left ventricular pressure and coronary flow (to 87±2% and 86±4% of initial respectively, n=11, p<0.01). These effects were blocked by prazosin and BMY 7378, suggesting
1D-AR-mediated responses. In contrast, trabeculae from ABKO hearts did not respond to phenylephrine, suggesting that in ABKO perfused hearts the effects of phenylephrine were not mediated by direct actions on cardiomyocytes. A novel finding was that
1-AR stimulation caused positive inotropy in the wild type mouse heart in contrast to the negative inotropy observed in mouse cardiac muscle strips. We conclude that mouse hearts lacking
1A- and
1B-ARs retain functional
1-AR responses involving decreases of coronary flow and ventricular pressure that reflect
1D-AR-mediated vasoconstriction. Furthermore,
1-AR inotropic responses depend critically on the experimental conditions.
This article has been cited by other articles:
![]() |
C. D. Wright, Q. Chen, N. L. Baye, Y. Huang, C. L. Healy, S. Kasinathan, and T. D. O'Connell Nuclear {alpha}1-Adrenergic Receptors Signal Activated ERK Localization to Caveolae in Adult Cardiac Myocytes Circ. Res., October 24, 2008; 103(9): 992 - 1000. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. T. McCloskey, S. Turcato, G.-Y. Wang, L. Turnbull, B.-Q. Zhu, T. Bambino, A. P. Nguyen, D. H. Lovett, R. A. Nissenson, J. S. Karliner, et al. Expression of a Gi-coupled receptor in the heart causes impaired Ca2+ handling, myofilament injury, and dilated cardiomyopathy Am J Physiol Heart Circ Physiol, January 1, 2008; 294(1): H205 - H212. [Abstract] [Full Text] [PDF] |
||||
![]() |
G.-Y. Wang, D. T. McCloskey, S. Turcato, P. M. Swigart, P. C. Simpson, and A. J. Baker Contrasting inotropic responses to {alpha}1-adrenergic receptor stimulation in left versus right ventricular myocardium Am J Physiol Heart Circ Physiol, October 1, 2006; 291(4): H2013 - H2017. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Turnbull, H.-Z. Zhou, P. M. Swigart, S. Turcato, J. S. Karliner, B. R. Conklin, P. C. Simpson, and A. J. Baker Sustained preconditioning induced by cardiac transgenesis with the tetracycline transactivator Am J Physiol Heart Circ Physiol, March 1, 2006; 290(3): H1103 - H1109. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. T. McCloskey, L. Turnbull, P. M. Swigart, A. C. Zambon, S. Turcato, S. Joho, W. Grossman, B. R. Conklin, P. C. Simpson, and A. J. Baker Cardiac transgenesis with the tetracycline transactivator changes myocardial function and gene expression Physiol Genomics, June 16, 2005; 22(1): 118 - 126. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Uberti, C. Hague, H. Oller, K. P. Minneman, and R. A. Hall Heterodimerization with {beta}2-Adrenergic Receptors Promotes Surface Expression and Functional Activity of {alpha}1D-Adrenergic Receptors J. Pharmacol. Exp. Ther., April 1, 2005; 313(1): 16 - 23. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z.-S. Jiang, W. Srisakuldee, F. Soulet, G. Bouche, and E. Kardami Non-angiogenic FGF-2 protects the ischemic heart from injury, in the presence or absence of reperfusion Cardiovasc Res, April 1, 2004; 62(1): 154 - 166. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |